Preclinical systemic toxicity evaluation of chitosan-solid lipid nanoparticle-encapsulated aspirin and curcumin in combination with free sulforaphane in BALB/c mice

References

• LazarouJPomeranzBHCoreyPNIncidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studiesJAMA199827915120012059555760
   PubMed Web of Science ®Google Scholar
• EinarsonTRDrug-related hospital admissionsAnn Pharmacother1993277–88328408364259
   PubMed Web of Science ®Google Scholar
• ScriptureCDFiggWDDrug interactions in cancer therapyNat Rev Cancer20066754655816794637
   PubMed Web of Science ®Google Scholar
• WynnRLErythromycin and ketoconazole (Nizoral) associated with terfenadine (Seldane)-induced ventricular arrhythmiasGen Dent199341127297489857
   PubMedGoogle Scholar
• WysowskiDKBacsanyiJCisapride and fatal arrhythmiaN Engl J Med199633542902918657260
   PubMed Web of Science ®Google Scholar
• MichaletsELWilliamsCRDrug interactions with cisapride: clinical implicationsClin Pharmacokinet2000391497510926350
   PubMed Web of Science ®Google Scholar
• WysowskiDKCorkenAGallo-TorresHTalaricoLRodriguezEMPostmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and food and drug administration regulatory actionsAm J Gastroenterol20019661698170311419817
   PubMed Web of Science ®Google Scholar
• JuurlinkDNMamdaniMKoppALaupacisARedelmeierDADrug-drug interactions among elderly patients hospitalized for drug toxicityJAMA2003289131652165812672733
   PubMed Web of Science ®Google Scholar
• WakasugiHYanoIItoTEffect of clarithromycin on renal excretion of digoxin: interaction with P-glycoproteinClin Pharmacol Ther19986411231289695727
   PubMed Web of Science ®Google Scholar
• BrownBAWallaceRJJrGriffithDEWardenRClarithromycin-associated digoxin toxicity in the elderlyClin Infect Dis199724192938994761
   PubMed Web of Science ®Google Scholar
• GuerrieroSEEhrenpreisEGallagherKLTwo cases of clarithromycin-induced digoxin toxicityPharmacotherapy1997175103510379324195
   PubMed Web of Science ®Google Scholar
• GrandhiBKThakkarAWangJPrabhuSA novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesionsCancer Prev Res201361010151025
   Web of Science ®Google Scholar
• VauthierCDubernetCChauvierreCBriggerICouvreurPDrug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticlesJ Control Release200393215116014636721
   PubMed Web of Science ®Google Scholar
• RamalingamPKoYTEnhanced oral delivery of curcumin from N-trimethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluationsPharm Res201532238940225082210
   PubMed Web of Science ®Google Scholar
• LuoYTengZLiYWangQSolid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptakeCarbohydr Polym201512222122925817662
   PubMed Web of Science ®Google Scholar
• AryaGVandanaMAcharyaSSahooSKEnhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapyNanomedicine20117685987021550422
   PubMed Web of Science ®Google Scholar
• RoyKMaoHQHuangSKLeongKWOral gene delivery with chitosan – DNA nanoparticles generates immunologic protection in a murine model of peanut allergyNat Med19995438739110202926
   PubMed Web of Science ®Google Scholar
• MaezakiYTsujiKNakagawaYHypocholesterolemic effect of chitosan in adult malesBiosci Biotechnol Biochem199357914391444
   PubMed Web of Science ®Google Scholar
• ChenMCMiFLLiaoZXRecent advances in chitosan-based nanoparticles for oral delivery of macromoleculesAdv Drug Deliv Rev201365686587923159541
   PubMed Web of Science ®Google Scholar
• YuanHJiangSPDuYZMiaoJZhangXGHuFQStrategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticlesColloids Surf B Biointerfaces200970224825319185474
   PubMed Web of Science ®Google Scholar
• SakloetsakunDPereraGHombachJMillottiGBernkop-SchnürchAThe impact of vehicles on the mucoadhesive properties of orally administrated nanoparticles: a case study with chitosan-4-thiobutylamidine conjugateAAPS PharmSciTech20101131185119220668967
   PubMed Web of Science ®Google Scholar
• FontePAndradeFAraújoFAndradeCNevesJSarmentoBChitosan-coated solid lipid nanoparticles for insulin deliveryMethods Enzymol201250829531422449932
   PubMed Web of Science ®Google Scholar
• ColeETScottRAConnorALEnteric coated HPMC capsules designed to achieve intestinal targetingInt J Pharm20022311839511719017
   PubMed Web of Science ®Google Scholar
• SutariaDGrandhiBKThakkarAWangJPrabhuSChemoprevention of pancreatic cancer using solid lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimenInt J Oncol20124162260226823007664
   PubMed Web of Science ®Google Scholar
• ThakkarASutariaDGrandhiBKWangJPrabhuSThe molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancerOncol Rep20132941671167723404329
   PubMed Web of Science ®Google Scholar
• Antithrombotic Trialists’ (ATT) CollaborationBaigentCBlackwellLAspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsLancet200937396781849186019482214
   PubMed Web of Science ®Google Scholar
• AjaniUAFordESGreenlandKJGilesWHMokdadAHAspirin use among U.S. adults: behavioral risk factor surveillance systemAm J Prev Med2006301747716414427
   PubMed Web of Science ®Google Scholar
• LanasAGastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practiceExpert Opin Drug Saf2011101455420645883
   PubMed Web of Science ®Google Scholar
• CaylaGColletJPSilvainJThiefinGWoimantFMontalescotGPrevalence and clinical impact of upper gastrointestinal symptoms in subjects treated with low dose aspirin: the UGLA surveyInt J Cardiol20121561697521093073
   PubMed Web of Science ®Google Scholar
• SikoraEScapagniniGBarbagalloMCurcumin, inflammation, ageing and age-related diseasesImmun Ageing201071120205886
   PubMedGoogle Scholar
• ChengALHsuCHLinJKPhase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesionsAnticancer Res2001214B2895290011712783
   PubMed Web of Science ®Google Scholar
• DhillonNAggarwalBBNewmanRAPhase II trial of curcumin in patients with advanced pancreatic cancerClin Cancer Res200814144491449918628464
   PubMed Web of Science ®Google Scholar
• NohJRKimYHHwangJHSulforaphane protects against acetaminophen-induced hepatotoxicityFood Chem Toxicol20158019320025818464
   PubMed Web of Science ®Google Scholar
• PhilbrookNAWinnLMSub-chronic sulforaphane exposure in CD-1 pregnant mice enhances maternal NADPH quinone oxidoreductase 1 (NQO1) activity and mRNA expression of NQO1, glutathione S-transferase, and glutamate-cysteine ligase: potential implications for fetal protection against toxicant exposureReprod Toxicol201443303724184564
   PubMed Web of Science ®Google Scholar
• JiaoZZhangQChangJA protective role of sulforaphane on alveolar epithelial cells exposed to cigarette smoke extractExp Lung Res201339937938624117145
   PubMed Web of Science ®Google Scholar
• SzeAEricksonDRenLLiDZeta-potential measurement using the Smoluchowski equation and the slope of the current-time relationship in electroosmotic flowJ Colloid Interface Sci2003261240241016256549
   PubMed Web of Science ®Google Scholar
• OECDTest 407: Repeated Dose 28-day Oral Toxicity Study in RodentsOECDParis
   Google Scholar
• OECDTest 408: Repeated Dose 90-Day Oral Toxicity Study in RodentsOECDParis
   Google Scholar
• de CastroMDIzquierdoALyophilization: a useful approach to the automation of analytical processes?J Automat Chem199012626727918925285
   PubMedGoogle Scholar
• YenFLWuTHTzengCWLinLTLinCCCurcumin nanoparticles improve the physicochemical properties of curcumin and effectively enhance its antioxidant and antihepatoma activitiesJ Agric Food Chem201058127376738220486686
   PubMed Web of Science ®Google Scholar
• SawantKKDodiyaSSRecent advances and patents on solid lipid nanoparticlesRecent Pat Drug Deliv Formul20082212013519075903
   PubMedGoogle Scholar
• KedarUPhutanePShidhayeSKadamVAdvances in polymeric micelles for drug delivery and tumor targetingNanomedicine20106671472920542144
   PubMed Web of Science ®Google Scholar
• WissingSAKayserOMüllerRHSolid lipid nanoparticles for parenteral drug deliveryAdv Drug Deliv Rev20045691257127215109768
   PubMed Web of Science ®Google Scholar
• JacobsCKayserOMüllerRHNanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepideInt J Pharm2000196216116410699709
   PubMed Web of Science ®Google Scholar
• DufourDRLottJANolteFSGretchDRKoffRSSeeffLBDiagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoringClin Chem200046122050206811106350
   PubMed Web of Science ®Google Scholar
• AmacherDEA toxicologist’s guide to biomarkers of hepatic responseHum Exp Toxicol200221525326212141396
   PubMed Web of Science ®Google Scholar
• OzerJRatnerMShawMBaileyWSchomakerSThe current state of serum biomarkers of hepatotoxicityToxicology2008245319420518291570
   PubMed Web of Science ®Google Scholar
• ZhangXDWuDShenXSize-dependent in vivo toxicity of PEG-coated gold nanoparticlesInt J Nanomedicine201162071208121976982
   PubMed Web of Science ®Google Scholar
• MillerWGMyersGLAshwoodERCreatinine measurement: state of the art in accuracy and interlaboratory harmonizationArch Pathol Lab Med2005129329730415737021
   PubMed Web of Science ®Google Scholar
• RosnerMHBoltonWKRenal function testingAm J Kidney Dis200647117418316377400
   PubMed Web of Science ®Google Scholar